Persons with opioid use disorder (OUD) hospitalized with severe, injection-related infections (SIRI) are frequently hospitalized for the duration of IV antibiotic treatment due to concerns regarding their eligibility for outpatient parenteral antimicrobial therapy (OPAT), which is the standard of care for prolonged IV antibiotic courses for patients without drug use. As part of a pilot study, a novel, integrated care model was developed where patients with OUD and SIRI receive addiction consultation and buprenorphine induction while hospitalized, followed by ongoing management in an outpatient clinic that combines office-based opioid treatment with buprenorphine pharmacotherapy and counseling services with OPAT. Through three illustrative case vignettes the outpatient model is described along with challenges, lessons learned and future directions.
|State||Published - Nov 2019|
Bibliographical noteFunding Information:
University of Kentucky College of Medicine Multidisciplinary Value Program, Office of the Vice President for Research, and the Center for Clinical and Translational Science , grant number UL1TR001998 .
University of Kentucky College of Medicine Multidisciplinary Value Program, Office of the Vice President for Research, and the Center for Clinical and Translational Science, grant number UL1TR001998.
© 2019 Elsevier Inc.
- Opiate-related disorders
- Substance abuse
- Vascular access devices
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health